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The majority of GLUT4 is sequestered in unique intra-
cellular vesicles in the absence of insulin. Upon insulin
stimulation GLUT4 vesicles translocate to, and fuse
with, the plasma membrane. To determine the effect of
GLUT4 content on the distribution and subcellular traf-
ficking of GLUT4 and other vesicle proteins, adipocytes
of adipose-specific, GLUT4-deficient (aP2-GLUT4/)
mice and adipose-specific, GLUT4-overexpressing (aP2-
GLUT4-Tg) mice were studied. GLUT4 amount was re-
duced by 80–95% in aP2-GLUT4/ adipocytes and in-
creased10-fold in aP2-GLUT4-Tg adipocytes compared
with controls. Insulin-responsive aminopeptidase (IRAP)
protein amount was decreased 35% in aP2-GLUT4/
adipocytes and increased 45% in aP2-GLUT4-Tg adipo-
cytes. VAMP2 protein was also decreased by 60% in aP2-
GLUT4/ adipocytes and increased 2-fold in aP2-
GLUT4-Tg adipocytes. IRAP and VAMP2 mRNA levels
were unaffected in aP2-GLUT4-Tg, suggesting that over-
expression of GLUT4 affects IRAP and VAMP2 protein
stability. The amount and subcellular distribution of
syntaxin4, SNAP23, Munc-18c, and GLUT1 were un-
changed in either aP2-GLUT4/ or aP2-GLUT4-Tg adi-
pocytes, but transferrin receptor was partially redis-
tributed to the plasma membrane in aP2-GLUT4-Tg
adipocytes. Immunogold electron microscopy revealed
that overexpression of GLUT4 in adipocytes increased
the number of GLUT4 molecules per vesicle nearly 2-fold
and the number of GLUT4 and IRAP-containing vesicles
per cell 3-fold. In addition, the proportion of cellular
GLUT4 and IRAP at the plasma membrane in unstimu-
lated aP2-GLUT4-Tg adipocytes was increased 4- and
2-fold, respectively, suggesting that sequestration of
GLUT4 and IRAP is saturable. Our results show that
GLUT4 overexpression or deficiency affects the amount
of other GLUT4-vesicle proteins including IRAP and
VAMP2 and that GLUT4 sequestration is saturable.
Insulin-stimulated glucose transport is essential for the
maintenance of glucose homeostasis in mammals. The GLUT4
glucose transporter mediates insulin-regulated glucose trans-
port (1–5). GLUT4 is expressed primarily in adipose tissue and
skeletal and cardiac muscle (1–5), although expression has also
been reported in kidney (2) and brain (6). In the absence of
insulin, GLUT4 resides primarily in intracellular vesicles (1–
5). The binding of insulin to its receptor initiates a cascade of
tyrosine phosphorylation events that promote translocation,
docking, and fusion of GLUT4-containing vesicles with the
plasma membrane, promoting glucose uptake by the cell (7).
This process plays a key role in normal physiology, and dys-
regulation of GLUT4 expression or trafficking is a major path-
ogenic factor in the insulin resistance seen in obesity and type
2 diabetes (8, 9).
Evidence suggests that, in addition to trafficking through the
endosomal recycling pathway, GLUT4 vesicles consist of a
unique intracellular storage compartment, separate from this
pathway (10, 11). In 3T3-L1 adipocytes and primary rat adipo-
cytes, GLUT4 is targeted to intracellular vesicles that are
distinct from those containing GLUT1 (12). Ectopic expression
of GLUT4 in neuroendocrine PC12 cells shows that GLUT4 is
targeted to neither synaptic vesicles nor secretory granules,
suggesting that GLUT4 forms a distinct class of storage vesi-
cles (13, 14). In addition, diaminobenzidine treatment of adi-
pocytes specifically ablates transferrin receptor (TfR)1 and cel-
lubrevin-containing endosomes, without eliminating a large
portion of GLUT4-containing endosomes (15). An insulin-re-
sponsive aminopeptidase (IRAP) was the first protein identi-
fied that co-localizes with GLUT4 specifically in its unique
intracellular compartment (16, 17). Like GLUT4, IRAP is ex-
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pressed in adipocytes and skeletal muscle (17) and in other
tissues. IRAP translocates with GLUT4 to the cell surface in
response to insulin (16). The function of IRAP and its relation-
ship to GLUT4 are unknown, although a recent study shows
that IRAP-null mice have decreased GLUT4 expression in mus-
cle and adipocytes (18).
Incorporation of vesicles into target membranes is mediated
by a high affinity interaction between a ligand on the vesicle
SNARE and receptors on the target membrane (target SNARE)
which mediate docking and fusion (11, 19). Two vesicle
SNAREs, VAMP2 (vesicle associated membrane protein 2) and
VAMP3 (cellubrevin), are expressed in adipocytes (20). Unlike
VAMP3, a large portion of adipocyte VAMP2 is targeted to the
GLUT4 vesicle, suggesting a role for VAMP2 in the mediating
GLUT4 trafficking (15). Adipocytes express two different target
SNAREs, syntaxin4 (21, 22) and SNAP23 (23, 24), which to-
gether bind VAMP2 and provide the necessary target SNARE
complex for vesicle fusion at the plasma membrane (25). Inter-
action between syntaxin4 and Munc-18c, which inhibits insu-
lin-stimulated GLUT4 translocation by blocking binding of syn-
taxin4 and VAMP2, may also be required for proper
incorporation of the GLUT4 vesicle into the plasma membrane
(26). Although the involvement of VAMP2, SNAP23, syntaxin4,
and Munc-18c in GLUT4-vesicle trafficking in normal adipo-
cytes has been established (11, 19), many questions remain
regarding the nature and regulation of GLUT4 vesicle number,
size, protein content, and trafficking. Adipocytes from trans-
genic mice in which GLUT4 has been markedly reduced or
overexpressed provide unique tools to learn more about the
regulation of GLUT4 vesicles.
We hypothesized that altering adipocyte GLUT4 content
may alter the protein composition, number, and/or sequestra-
tion of GLUT4-containing vesicles but not affect plasma mem-
brane proteins mediating GLUT4 trafficking or other proteins
trafficking through endosomes in response to insulin. We
showed previously (27) in adipocytes from GLUT4-overexpress-
ing mice that the polypeptide composition of immunoabsorbed
GLUT4 vesicles was similar to control except for increased
GLUT4 and a modest increase in aminopeptidase activity (pre-
sumably IRAP). We hypothesized that there were either more
GLUT4 per vesicle or more vesicles with GLUT4. However,
we did not assess the distribution of GLUT4 or other vesicle
proteins between the plasma membrane and intracellular
membranes nor the effect of GLUT4 deficiency on vesicle
characteristics.
Here we employ complementary techniques to determine
whether adipocyte GLUT4 content changes the characteristics
of GLUT4 vesicles, using adipocytes of adipose-specific,
GLUT4-deficient (aP2-GLUT4/) mice (28) or adipose-spe-
cific, GLUT4-overexpressing (aP2-GLUT4-Tg) mice (29). We
show that overexpression or deficiency of GLUT4 in adipocytes
causes a corresponding change in IRAP and VAMP2 protein
levels. IRAP and VAMP2 mRNA levels are unaltered by
GLUT4 overexpression, suggesting that increased GLUT4 may
alter the turnover of these proteins. Levels of plasma mem-
brane proteins syntaxin4, SNAP23, and Munc-18c, which me-
diate GLUT4-vesicle docking and fusion with plasma mem-
branes, are unchanged. Levels of GLUT1, which traffics to the
plasma membrane primarily from a different intracellular com-
partment than GLUT4, are unchanged. Interestingly, the sub-
cellular distribution of TfR, an early endosomal protein, is
altered by high level GLUT4 overexpression, whereas the dis-
tribution of GLUT1 is not affected. Immunogold EM analysis
shows that overexpression of GLUT4 increases the amount of
GLUT4 per vesicle as well as the number of GLUT4- and
IRAP-containing vesicles per cell. In addition, GLUT4 overex-
pression results in an increased proportion of GLUT4 at the
plasma membrane in the absence of insulin, supporting the
notion that GLUT4 sequestration is saturable. This could occur
at the level of retention, endocytosis, and/or recycling of
GLUT4 from the plasma membrane to intracellular stores. Our
results also indicate that GLUT4 is a major determinant of
GLUT4 vesicle net biogenesis and sequestration in vivo.
EXPERIMENTAL PROCEDURES
Mice—Adipose-specific GLUT4/ mice (28) and adipose-specific
GLUT4-overexpressing mice (29) were housed at 22 °C with a 12-h
light/dark cycle and fed standard rodent chow ad libitum. Mice were
genotyped as described previously (28, 29). All studies were carried out
in mice 12–16 weeks of age in accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Animals. Similar
results were observed in adipocytes from male and female mice.
Isolation of Adipocytes and Determination of Glucose Transport and
Cell Size and Number—Perigonadal fat pads (1–2 g) from fed male or
female mice sacrificed by CO2 inhalation (10 per genotype for each
experiment) were weighed, finely minced in Krebs buffer containing 20
mM Hepes, 2.5% bovine serum albumin (Internee, New York), and 200
nM adenosine, pH 7.4, at 37 °C, and digested for 30–40 min at 37 °C
with constant shaking by addition of collagenase (1 mg/ml, Worthing-
ton). Following digestion, cells were passed through a 200-m mesh
(Tekko, Kansas City, MO) and washed four times with buffer, and 20%
suspensions of cells were incubated in the absence or presence of 100 nM
regular porcine insulin (Lilly) for 30 min with constant shaking at 37 °C
(29, 30).
Uptake of [U-14C]glucose into isolated adipocytes (20% cell suspen-
sions) was measured in the presence or absence of 100 nM porcine
regular insulin for 30 min at 37 °C as described previously (29, 30).
Aliquots of adipocytes were fixed in osmic acid and counted in a Coulter
counter (31). To determine cell size, adipocyte mass was determined in
quadruplicate by dividing the lipid content of the cell suspension by the
cell number (31).
Preparation of Total Membranes from Adipose Tissue and Isolated
Adipocytes—Adipose tissue (from either perigonadal or subcutaneous
fat depots) or isolated adipocytes were homogenized with a Polytron
(“Tissue Tearer” homogenizer; Biospec Products, Inc., Bartlesville, OK)
in 10 mM Hepes, 5 mM EDTA, 250 mM sucrose with 10 g/ml aprotinin
and 10 g/ml leupeptin. Homogenates were centrifuged at 12,000  g
for 10 min at 4 °C to remove insoluble material. The supernatant was
centrifuged at 223,000  g for 90 min at 4 °C. The resulting pellet was
resuspended to a concentration of 2 g/l in homogenization buffer,
and total membrane proteins were stored at 80 °C.
Preparation of Subcellular Membrane Fractions from Isolated Adi-
pocytes—Isolated adipocytes (20% cell suspensions), after a 30-min
incubation at 37 °C in the absence or the presence of 80 nM insulin, were
washed twice with TES buffer (20 mM Tris, 1 mM EDTA, 255 mM
sucrose, pH 7.4 at 20 °C) at 15–18 °C and homogenized in TES at 4 °C
using 15 strokes of a Potter drill per sample. Aliquots of homogenates
were collected and stored at 80 °C. Remaining homogenates were
centrifuged at 16,000  g for 15 min at 4 °C, and surface solidified fat
was removed. High density microsomal membranes and low density
microsomal membranes (LDM) were isolated from supernatants, and
plasma membranes (PM) were isolated from the pellets. Pellets con-
taining PM were resuspended in TES, using 10 strokes of a Potter drill,
and centrifuged at 16,000 g 4 °C for 20 min. Pellets were resuspended
in TES, layered on a 1.12 M sucrose cushion in 20 mM Tris-HCl, 1 mM
EDTA, and centrifuged at 100,000  g for 20 min at 4 °C. Plasma
membranes at the interface between the sucrose cushion and buffer
were collected, resuspended in TES, and centrifuged at 100,000  g for
30 min at 4 °C. Plasma membrane pellets were resuspended to2 g/l
in TES.
For preparation of microsomal membrane fractions, supernatants
were centrifuged at 4 °C for 20 min at 50,000  g. LDM was isolated
from supernatants, and high density microsomal membranes were iso-
lated from pellets. Pellets were resuspended in TES and centrifuged at
4 °C for 20 min at 50,000  g and resuspended at 1 g/l. Superna-
tants containing LDM were centrifuged at 200,000  g for 90 min 4 °C;
LDM pellets were resuspended at 2 g/l. All membranes were kept
at 80 °C until use.
Purity, Enrichment, and Recovery of Subcellular Fractions—Purity
of PM fractions was determined by immunoblotting for Ras, which is
located exclusively in PM (32). Purity of LDM fractions was determined
by immunoblotting for -coatomer protein (-COP), a marker for LDM
(33). Cross-contamination of fractions was negligible by immunoblot-
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ting. Immunoblots were quantitated by densitometry (Amersham Bio-
sciences). PM enrichment was calculated as (OD of Ras in the PM/g of
PM protein)/(OD of Ras in the homogenate/g of homogenate protein);
similarly, LDM enrichment was calculated as (OD of -COP in the
LDM/g of LDM protein)/(OD of -COP in the homogenate/g of homo-
genate protein). PM enrichment with Ras averaged 9-fold greater than
in homogenates. LDM enrichment with -COP averaged 20-fold greater
than in homogenates. Protein recoveries for all membrane fractions
were similar between aP2-GLUT/, aP2-GLUT4-Tg, and control
adipocytes.
Gel Electrophoresis and Immunoblotting—Proteins were separated
in 10 or 14% SDS-PAGE (NOVEX gels, Invitrogen) and transferred
electrophoretically to nitrocellulose. Proteins were immunoblotted with
anti-GLUT4 (gift of H. Haspel), anti-GLUT1 (gift of B. Thorens), anti-
IRAP (gift of S. Keller), anti-human TfR (Zymed Laboratories Inc., San
Francisco, CA), anti-VAMP2 (gift of M. Knepper), anti-SNAP23 (gift of
M. Knepper), anti-Akt1 (Upstate Biotechnology, Lake Placid NY),
-COP (Affinity Bioreagents, Golden CO), or anti-Ras (Santa Cruz
Biotechnology, Santa Cruz, CA) antibodies, according to the manufac-
turer’s instructions or as described previously (28, 34, 35). Proteins
were visualized by ECL, and autoradiograms of immunoblots were
quantitated by densitometry.
Quantitative Real-time PCR—IRAP and VAMP2 mRNA from iso-
lated adipocytes of control and aP2-GLUT4-Tg mice were quantified by
quantitative real-time reverse transcriptase-PCR using an ABI Prism
7700 sequence detection system (Applied Biosystems, Foster City, CA).
Total RNA was extracted from isolated adipocytes using Trizol (Invitro-
gen). Total RNA concentrations were quantified in triplicate, and re-
verse transcriptase-PCRs for IRAP and 18 S RNA or VAMP2 and 18 S
RNA were done in duplicate using 100 ng of total RNA for each sample.
Sense 5-GAAATTGGATTTGGTGGCCA-3 and antisense 5-TCG-
GAATGTAAGCAGGCCC-3 primers and probe 5-FAM-CCTGACTTT-
GAAGCAGGAGCAATGGAAAAC-TAMRA-3 specific for the mouse
IRAP nucleotide sequence were used for cDNA synthesis and PCR
amplification. Sense 5-CCTGCACCTCCTCCAAACC-3 and antisense
5-CACCACCTCATCCACCTGG-3 primers and probe 5-FAM-CTAG-
TAACAGGAGACTGCAGCAGACCCAGG-TAMRA-3 specific for the
mouse VAMP2 nucleotide sequence were used for cDNA synthesis and
PCR amplification. Total RNAs were reverse-transcribed and amplified
using the Taqman One-step PCR Master Mix Reagent (Applied Biosys-
tems) following the manufacturer’s instructions. Reverse transcription
was carried out at 48 °C for 30 min and terminated at 95 °C for 10 min.
Reactions were amplified for 35 cycles at 95 °C for 15 s and 60 °C for
60 s.
Photolabeling of Glucose Transporters—Photolabeling was carried as
described (36). Adipocytes from 5 g of perigonadal fat of control and
aP2-GLUT4-Tg mice were isolated, incubated for 30 min at 37 °C in the
absence or the presence of 80 nM insulin, washed with bovine serum
albumin-free KRBH buffer, and UV-irradiated 3 times for 1 min in the
presence of 500 Ci of ATB-BMPA. After insulin incubation, 1 aliquot
was separated for glucose transport measurements in the same cells.
The cells were separated from unincorporated label by centrifugation
through dinonyl phthalate oil and solubilized for 30 min in room tem-
perature in 2% Thesit plus protease inhibitors (aprotinin, leupeptin,
phenylmethylsulfonyl fluoride, 2 macroglobulin and pepstatin). Ly-
sates were centrifuged at 100,000  g for 10 min at 2 °C, and GLUT4
was immunoprecipitated from supernatants with anti-GLUT4 antibody
conjugated to protein A-Sepharose at 4 °C for 2 h. Immunoprecipitates
were extracted with chloroform/methanol (1:4), washed twice with 0.2%
Thesit plus inhibitors and twice with phosphate-buffered saline, and
GLUT4 was eluted with 2.3 M urea, 1.5% SDS, 100 mM dithiothreitol,
20% glycerol, and bromphenol blue, pH 6.8. The eluate was separated
from GLUT4 antibody-protein A-Sepharose beads by filtration through
0.45-m filters (Millipore, Bedford, MA). Eluate proteins were resolved
by electrophoresis on 10% Tris-glycine gels and stained with Coomassie
Brilliant Blue R-250. Each lane of protein was cut into 25 slices per-
pendicular to the direction of migration; slices were baked in glass vials
for a minimum of 3 h at 80 °C, cooled to room temperature, solubilized
in H2O2/NH3OH (98:2), baked for 3 h at 80 °C, cooled to room temper-
ature, and counted in scintillation fluid. Results are expressed as
counts/min per gel slice and corrected for the number of cells in each
genotype.
Immunogold Electron Microscopy—Intracellular membrane vesicles
were prepared from isolated adipocytes from control and aP2-
GLUT4-Tg mice. Adipocytes were homogenized in HES buffer (20 mM
Hepes, 1 mM EDTA, 250 mM sucrose, 10 g/ml leupeptin, 10 g/ml
aprotinin, and 250 M phenylmethylsulfonyl fluoride, pH 7.4), and
homogenates were centrifuged at 4 °C for 20 min at 13,000  g to
remove cellular debris, plasma membranes, mitochondria, and nuclei.
Supernatants were layered over a 1.5 M sucrose cushion and centrifuged
at 111,000  g for 60 min at 4 °C. Intracellular membranes were
harvested at the interface and were fixed with an equal volume of 4%
paraformaldehyde/phosphate-buffered saline. Vesicles were adsorbed
to Formvar-coated copper grids that were incubated sequentially with
primary antibody (GLUT4 1:400, or VAMP2 10 g/ml, or IRAP 1:500)
followed by protein A gold. For double labeling, the first label was
stabilized on 1% glutaraldehyde. Vesicles were stained with a mixture
of uranyl acetate and methylcellulose.
RESULTS
Effect of GLUT4 Amount on Fat Pad Weight, Adipocyte Size,
and Glucose Transport in Adipocytes—Adipose-specific
GLUT4-overexpressing (aP2-GLUT4-Tg) mice have increased
perigonadal fat pad weight (Table I) due to adipocyte hyperpla-
sia (29). Fat pad weight (Table I) and adipocyte cell number
(28) are normal in adipose-specific, GLUT4-deficient (aP2-
GLUT4/) mice. Adipocyte size in perigonadal fat pads of
aP2-GLUT4/ mice and aP2-GLUT4-Tg mice is similar to
controls (Table I) as reported previously (28, 29).
In aP2-GLUT4/ adipocytes, basal glucose transport
tended to be decreased by 57% compared with controls (Fig. 1,
left panel). Insulin-stimulated glucose transport was decreased
by 78%, as reported previously (28). The residual glucose trans-
port is probably due to the presence of GLUT1 and to GLUT4
remaining in a small subset of adipocytes that escaped Cre
recombinase-mediated deletion.
In aP2-GLUT4-Tg adipocytes, basal glucose transport was
increased 30-fold and insulin-stimulated glucose transport
10-fold compared with control (Fig. 1, right panel), as ob-
served previously (29). The increase in glucose transport with
insulin stimulation was 4.8-fold for control adipocytes but only
1.7-fold for aP2-GLUT4-Tg adipocytes. However, the increment
in glucose transport above basal (insulin-stimulated minus
basal) was 8-fold higher in aP2-GLUT4-Tg than in control
adipocytes.
GLUT4 Deficiency or Overexpression Causes Concordant
Changes in IRAP and VAMP2—Immunoblots of total mem-
brane proteins from isolated adipocytes of control, aP2-
GLUT4/, and aP2-GLUT4-Tg mice showed that GLUT4
protein levels in aP2-GLUT4/ adipocytes were approxi-
mately one-tenth the level of control littermates (Fig. 2A, left
TABLE I
Body weight, fat pad weight, and adipocyte size of control, aP2-GLUT4/, and aP2-GLUT4-Tg mice
Genotype Na Body weightb Fat pad weightb nc Adipocyte sizeb
g g g lipid/cell
Control (outbred FVB/C57/129) 24 34.55  1.57 0.55  0.05 4 0.361  0.011
aP2-GLUT4/ 14 33.55  1.09 0.45  0.04 4 0.322  0.038
Control (FVB) 39 28.43  0.70 0.41  0.03 4 0.320  0.024
aP2-GLUT4-Tg 31 29.43  0.91 0.64  0.05d 4 0.351  0.03
a N indicates numbers for body weight and fat pad weight.
b Body weight, epididymal fat pad weight, and adipocyte cell size of 4–6-month-old male mice.
c n indicates the number of experiments for adipocyte size. Each experiment was performed on pools of adipocytes from 6–10 mice per genotype.
d p  0.0002 versus control.
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panel), indicating an 90% “knockout” of GLUT4 (28). Most
interesting, IRAP and VAMP2 protein levels were also reduced
35 and 60%, respectively, in adipocytes of aP2-GLUT4/
mice compared with controls, whereas expression of the serine/
threonine kinase Akt did not change (aP2-GLUT4/ Akt
129 23% of WT) (Fig. 2, A and B, left panels). Similar changes
in GLUT4, IRAP, and VAMP2 were obtained from adipose
tissue of WT and aP2-GLUT/ mice (data not shown). This
suggests that GLUT4 content may influence the synthesis or
turnover of other GLUT4 vesicle proteins.
In aP2-GLUT4-Tg isolated adipocyte membranes, GLUT4
was overexpressed 9–12-fold compared with control litter-
mates (Fig. 2A, right panel), as reported previously (29). IRAP
and VAMP2 protein levels were also increased by 45 and
100% in aP2-GLUT4-Tg adipocytes compared with control,
whereas expression of Akt was unchanged (aP2-GLUT4-Tg Akt
78  10% of WT) (Fig. 2, A and B, right panels). Similar
changes in GLUT4, IRAP, and VAMP2 were obtained from
adipose tissue of WT and aP2-GLUT-Tg mice (data not shown).
Thus, overexpression of GLUT4 in aP2-GLUT4-Tg adipocytes
results in concordant increases in IRAP and VAMP2. The re-
ciprocal changes in IRAP in adipocytes of mice overexpressing
or deficient in GLUT4 strengthens the hypothesis that GLUT4
content may regulate IRAP protein levels and/or the generation
of GLUT4-IRAP-containing vesicles.
Subcellular Distribution of GLUT4 and IRAP Changes with
Increased GLUT4 Content—To determine whether changes in
GLUT4 amount altered the subcellular distribution of GLUT4
and other proteins in the GLUT4-vesicle, GLUT4, IRAP, and
VAMP2 levels in PM and LDM fractions of control, aP2-
GLUT4/, and aP2-GLUT4-Tg adipocytes were determined
by immunoblotting (Fig. 3A). Similar numbers of adipocytes
from each genotype were used for subcellular fractionation to
facilitate comparison. Proteins from PM and LDM fractions
were immunoblotted with antisera specific for Ras, a plasma
membrane marker (32), or -coatomer protein (-COP), a
Golgi-related protein and LDM marker (33), to determine the
purity of subcellular fractions. Cross-contamination of subcel-
lular fractions was negligible using this method (data not
shown). PM enrichment with Ras averaged 9  4-fold greater
than in homogenates. LDM enrichment with -COP averaged
20  6-fold greater than in homogenates. Recoveries and en-
richment of PM and LDM proteins from subcellular membrane
fractionation experiments were similar in control, aP2-
GLUT4/, and aP2-GLUT4-Tg adipocytes (data not shown).
Thus, the distribution of proteins among fractions could be
directly compared. The difference in enrichment/purity of PM
compared with LDM may account for the fact that the sum of
GLUT4 in PM plus LDM in the basal state does not appear to
equal the sum of GLUT4 in PM plus LDM in the insulin-
stimulated state (Fig. 3B).
In control adipocytes in the basal state, 8% of GLUT4 was
PM-associated and 92% of GLUT4 was LDM-associated (Fig.
3B). This was calculated by taking into account the concentra-
tion of GLUT4 per mg of membrane protein and the total
amount of membrane protein for each fraction (37, 38). Upon
insulin stimulation, 52% of GLUT4 was PM-associated and
48% of GLUT4 was LDM-associated (Fig. 3B). In aP2-
GLUT4/ adipocytes, a similar distribution of GLUT4 was
observed, although the overall amount of GLUT4 was reduced
5-fold, similar to the reduction in GLUT4 in total adipocyte
membranes (Fig. 2). In the basal state, 4.7% of GLUT4 was
PM-associated and 95% of GLUT4 was LDM-associated (Fig.
3B). In insulin-stimulated aP2-GLUT4/ adipocytes, 52% of
GLUT4 was in the PM, whereas 48% of GLUT4 was in the
LDM (Fig. 3B). The similar distribution of GLUT4 in control
FIG. 1. Glucose transport into isolated adipocytes of control
and adipose-specific GLUT4/ (knockout, KO) (left panel), and
control and adipose-specific GLUT4-overexpressing (TG) mice
(right panel). Results are means S.E. of three separate experiments,
each performed on pools of adipocytes from 4 to 10 mice per genotype.
*, p  0.05 compared with the corresponding control condition.
FIG. 2. IRAP and VAMP2 protein
levels in isolated adipocytes change
in parallel with GLUT4 levels. Total
membrane proteins were prepared from
isolated adipocytes of control and adipose-
specific GLUT4/ (KO) mice (left pan-
els) and control and adipose-specific
GLUT4-overexpressing (TG) mice (right
panels). Membrane proteins were immu-
noblotted with anti-GLUT4, anti-IRAP,
anti-VAMP2 or anti-Akt antisera, as indi-
cated. A, representative autoradiograms
of immunoblots. Each lane contains iso-
lated adipocyte membrane protein from
an individual mouse of the specified gen-
otype. B, IRAP and VAMP2 immunoblots
were quantitated by densitometry. Re-
sults are means  S.E. of control (Con,
n  7) and knockout (KO, n  8) (left) or
control (Con, n  17) and transgenic (TG,
n  15) (right) mice. Similar results for
GLUT4, IRAP, and VAMP2 were ob-
tained with adipose tissue (not shown). *,
p  0.05 compared with control.
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and aP2-GLUT4/ adipocytes was not unexpected. Residual
GLUT4 in aP2-GLUT4/ adipocytes is from a small number
of cells that escape Cre recombinase-mediated GLUT4 deletion
thus retaining their full complement of GLUT4. In contrast, in
basal aP2-GLUT4-Tg adipocytes, 31% of GLUT4 was PM-asso-
ciated and 69% of GLUT4 was LDM-associated (Fig. 3B). In
insulin-stimulated aP2-GLUT4-Tg adipocytes, 58% of GLUT4
was in the PM, whereas 42% of GLUT4 was in the LDM (Fig.
3B). The increased proportion of GLUT4 in the PM in both
basal and insulin-stimulated states suggests that intracellular
sequestration of GLUT4 is saturable. When data were ex-
pressed as total amount of GLUT4 per fraction in the basal or
insulin-stimulated state, the results were the same.
The subcellular distribution of IRAP corresponded to GLUT4
distribution in control, aP2-GLUT4-, and aP2-GLUT4-Tg adi-
pocytes. In control adipocytes, 11% of IRAP was PM-associated,
and 89% of IRAP was LDM-associated (Fig. 3B). Upon insulin
stimulation, 31% of IRAP was PM-associated, and 69% of IRAP
was LDM-associated (Fig. 3B). In aP2-GLUT4/ adipocytes,
a similar distribution of IRAP was observed, although the
overall amount of IRAP was reduced 55%, similar to the reduc-
tion of IRAP observed in the total membrane preparation (Fig.
2B). In the basal state, 4% of IRAP was PM-associated and 96%
of IRAP was LDM-associated (Fig. 3B). In insulin-stimulated
aP2-GLUT4/ adipocytes, 50% of IRAP was in the PM, and
50% of IRAP was in the LDM (Fig. 3B). In aP2-GLUT4-Tg
adipocytes, the 1.7-fold increase in IRAP was associated with
altered subcellular distribution, similar to what was observed
for GLUT4. In the basal state in aP2-GLUT4-Tg adipocytes,
24% of IRAP was PM-associated, and 76% of IRAP was LDM-
associated in the basal state (Fig. 3B). In insulin-stimulated
aP2-GLUT4-Tg adipocytes, 49% of IRAP was in the PM, and
51% of IRAP was in the LDM (Fig. 3B). Thus, not only was
there a small increase in the overall cellular content of IRAP
but the percentage of IRAP localized to the PM in the basal
state was also increased, similar to what was observed
for GLUT4.
Overexpression or reduction in GLUT4 also resulted in con-
cordant changes in VAMP2 in all subcellular membrane frac-
tions. However, unlike for IRAP, there was no effect on VAMP2
subcellular distribution (Fig. 3B), presumably because VAMP2
is present in many intracellular vesicles and not unique to the
GLUT4-vesicle compartment. GLUT4 overexpression did not
alter the amount or distribution of several other proteins
thought to be involved in GLUT4 trafficking. Syntaxin4,
SNAP23, Munc-18C, and GLUT1 were not altered by GLUT4
deficiency (Fig. 4A) or overexpression (Fig. 4B). In contrast,
there was a disproportionate increase in TfR in the PM relative
to the LDM in aP2-GLUT4-Tg adipocytes (Fig. 4B), suggesting
that overexpression of GLUT4 may impact trafficking of some
proteins through early endosomes (39).
GLUT4 Overexpression Increases GLUT4 in the Plasma
Membrane of Intact Adipocytes in Basal and Insulin-stimulated
States—Recent studies have delineated several steps in the
trafficking of GLUT4 vesicles to the PM from intracellular
stores (19). GLUT4 vesicles first dock at the PM prior to fusing
with the membrane (19). GLUT4 detected in PM fractions may
be either in GLUT4 vesicles which have docked, but not yet
fused with the PM, or GLUT4 fully inserted in the PM (11). To
determine whether the increased GLUT4 detected in PM frac-
tions of aP2-GLUT4-Tg adipocytes is from vesicles that have
fused with the PM, we photolabeled cell surface GLUT4 in
intact adipocytes before and after treatment with insulin. Glu-
cose transport was performed in aliquots of the same cells.
In intact control adipocytes, insulin increased cell surface
GLUT4 2.1-fold (Fig. 5A). In aP2-GLUT4-Tg adipocytes, basal
plasma membrane GLUT4 is 4-fold higher, and insulin-stimu-
lated plasma membrane GLUT4 is 2.4-fold higher compared
with control (Fig. 5A). In basal and insulin-stimulated aP2-
GLUT4-Tg adipocytes, increased cell surface GLUT4 detected
by photolabeling correlates with increased glucose transport
(Figs. 1 and 5B) and increased GLUT4 in plasma membrane
fractions (Fig. 3). Taken together, these data show that high
level overexpression of GLUT4 in adipocytes increases the pro-
portion of GLUT4 that is functionally inserted in the PM of
basal and insulin-stimulated cells, presumably due to satura-
tion of the intracellular retention mechanism for GLUT4, al-
though a defect in endocytosis cannot be ruled out. The satu-
ration may involve multiple steps in GLUT4 trafficking,
including retention of GLUT4 intracellularly as well as recy-
cling of GLUT4 from PM to intracellular storage pools.
Overexpression of GLUT4 in Adipocytes Increases the Num-
ber of GLUT4 and IRAP-containing Vesicles and the Amount of
GLUT4 per Vesicle—We assessed the amount of GLUT4 per
FIG. 3. IRAP and VAMP2 protein
levels in adipocyte subcellular mem-
brane fractions change in parallel
with GLUT4 protein levels. Plasma
membranes (PM) or low density microso-
mal membranes (LDM) were prepared
from isolated adipocytes from control and
adipose-specific GLUT4/ mice (KO)
mice or control and adipose-specific
GLUT4-overexpressing (TG) mice (n 
10–24 mice per genotype) after incuba-
tion in the absence () or presence () of
100 nM insulin. PM and LDM proteins
were immunoblotted with anti-GLUT4,
anti-IRAP, or anti-VAMP2 antisera. A,
representative autoradiograms of GLUT4
and IRAP. B, immunoblots for GLUT4,
IRAP, and VAMP2 from four separate ex-
periments were quantitated by densitom-
etry, and means  S.E. of control, knock-
out (KO), or transgenic (Tg) mice are
shown. Data for control adipocytes are ex-
pressed as relative OD units. *, p  0.05,
area under all the bars is significantly
different from control. #, p  0.05, subcel-
lular distribution of protein is signifi-
cantly different from control.
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vesicle, the number of GLUT4-containing vesicles per cell and
the percent of intracellular vesicles containing GLUT4, IRAP,
and VAMP2 in control and aP2-GLUT4-Tg adipocytes by im-
munogold EM. Representative micrographs are shown in Fig.
6A, and the quantification of 	200 vesicles per genotype is
shown in Fig. 6, B–E. Immunogold EM shows 10.4  1.9% of
intracellular vesicles staining for GLUT4 in control mice (Fig.
6B). In aP2-GLUT4-Tg mice, 29.8  4.4% of intracellular ves-
icles stain for GLUT4 (Fig. 6B), demonstrating that overex-
pression of GLUT4 results in a 3-fold increase in the number of
vesicles per cell that contain GLUT4. The percent of aP2-
GLUT4-Tg adipocyte vesicles that contain IRAP is also in-
creased 3-fold compared with controls (Fig. 6B).
The percentage of vesicles that contain IRAP and also
GLUT4 was similar in control (74  8) and aP2-GLUT4-Tg
(86  5), and GLUT4 vesicles containing IRAP were compara-
ble in control (35  9) and aP2-GLUT4-Tg (40  9). Addition-
ally, a similar percentage of control (25 14) or aP2-GLUT4-Tg
(25  11) GLUT4 vesicles contained VAMP2. However, 55% of
control VAMP2 vesicles contained GLUT4, but nearly all (86%)
aP2-GLUT4-Tg VAMP2 vesicles contained GLUT4, an increase
of 60% (Fig. 6C). Overall, these results demonstrate that over-
expression of GLUT4 results in an increased number of IRAP-
containing vesicles and in GLUT4 localization to an increased
percentage of VAMP2 vesicles, suggesting that GLUT4 intra-
cellular trafficking may be saturated.
The amount of GLUT4 per intracellular vesicle is increased
80% in aP2-GLUT4-Tg mice compared with control (Fig. 6D).
The average diameter of aP2-GLUT4-Tg adipocyte GLUT4 ves-
icles was unchanged compared with control (Fig. 6E). Thus,
overexpression of GLUT4 in adipocytes increases the amount of
GLUT4 per vesicle as well as the number of vesicles containing
GLUT4 and IRAP per cell.
GLUT4 Overexpression Does Not Change IRAP or VAMP2
mRNA Levels in Adipocytes—To determine whether the alter-
ations in IRAP and VAMP2 protein content observed in aP2-
GLUT4-Tg adipocytes were due to changes in mRNA levels,
steady-state levels of IRAP and VAMP2 mRNA were quanti-
tated by real-time reverse transcriptase-PCR. IRAP and
VAMP2 mRNA levels were similar in adipose tissue of control
and aP2-GLUT4-Tg (IRAP, 93  20% of control; VAMP2, 81 
23% of control) mice. Also, in isolated adipocytes the values
were similar. Thus, GLUT4 may regulate IRAP and VAMP2
protein amount either by translational regulation or by protein
sorting/turnover.
DISCUSSION
Intracellular Sequestration of GLUT4 Is Saturable in Adipo-
cytes—A major finding of this study is that GLUT4 overexpres-
sion in adipocytes causes subcellular redistribution of GLUT4.
Changes in GLUT4 subcellular distribution upon GLUT4 over-
expression paralleled increases in glucose transport. Data are
consistent using three independent techniques as follows: sub-
cellular fractionation, photolabeling, and immunogold EM.
Taken together, these results demonstrate that intracellular
sequestration of GLUT4 in adipocytes is saturable. We showed
previously GLUT4 is targeted to specific vesicles in adipocytes
of aP2-GLUT4-Tg mice, which have a similar composition to
control adipocytes (27). However, we examined only intracellu-
lar vesicles, and we could not rule out that GLUT4 might also
be present in other structures that are more likely to target to
the plasma membrane. In this study we show that the propor-
tional increase in GLUT4 in the PM is greater than in the
LDM. Our results suggest that this apparent saturation of
intracellular retention may be due, at least in part, to the fact
that high level GLUT4 overexpression alters intracellular tar-
geting of GLUT4. Our immuno-EM studies show that GLUT4
overexpression in adipocytes increases the amount of GLUT4
per vesicle as well as the number of GLUT4-containing vesi-
cles. Thus, GLUT4 overexpression not only increases plasma
membrane GLUT4 but also redistributes intracellular GLUT4
among intracellular vesicles.
We have shown previously (27) that GLUT4-containing ves-
icles from both WT and aP2-GLUT4-Tg adipocytes exclude
GLUT1, a glucose transporter that resides in a different vesicle
population than GLUT4 and traffics to the PM more constitu-
tively. These data are consistent with the lack of effect of
GLUT4 overexpression on GLUT1 subcellular distribution
(Fig. 4). However, the modest redistribution of TfR in the
aP2-GLUT4-Tg adipocytes compared with WT (Fig. 4) indicates
FIG. 4. Syntaxin4, SNAP23, Munc-
18C, GLUT1, and TfR protein levels
in adipocyte subcellular membrane
fractions from of GLUT4/ and TG
mice. Plasma membranes (PM) or low
density microsomal membranes (LDM)
were prepared from (A) control and adi-
pose-specific GLUT4/ (KO) adipocytes
and (B), control and adipose-specific
GLUT4-overexpressing (TG) adipocytes
(B) (n  10–24 mice per genotype, four
separate experiments). Adipocytes from
control, GLUT4/, and TG mice were
incubated in the absence () or presence
() of 100 nM insulin for 30 min prior to
fractionation. PM and LDM proteins were
immunoblotted with anti-syntaxin4, anti-
SNAP 23, anti-Munc-18c, anti-GLUT1, or
anti-TfR antisera as indicated.
FIG. 5. Overexpression of GLUT4 increases cell surface GLUT4
in basal and insulin-stimulated adipocytes. A, photolabeled cell
surface GLUT4, and B, glucose transport in isolated adipocytes of
control and adipose-specific GLUT4-overexpressing (TG) mice before
() and after () treatment with 100 nM insulin. Results are means 
S.E. for three separate experiments. *, p  0.05 compared with the
corresponding control condition.
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there is some effect of GLUT4 overexpression on the constitu-
tive endocytic pathway.
Data regarding whether overexpression of GLUT4 saturates
its sequestration are conflicting. In a study with rat adipocytes
overexpressing hemagglutinin-tagged GLUT4, increases in
plasma membrane GLUT4 were proportional to the overall
increase in GLUT4 expression, suggesting that GLUT4 seques-
tration is not saturable (40). However, our results are consist-
ent with several earlier studies. Overexpression of a carboxyl-
terminal 43-amino acid GLUT4 peptide increased basal plasma
membrane GLUT4 in rat adipocytes in vitro (41). Interestingly,
overexpression of a 27-amino acid peptide of IRAP similarly
redistributed GLUT4 to the plasma membrane in unstimulated
3T3-L1 adipocytes (42). Another study in which GLUT4 was
overexpressed by its own promoter demonstrated dispropor-
tionately increased plasma membrane GLUT4 in adipocytes
and cardiac myocytes in the basal state (43). Transgenic over-
expression of GLUT4 in muscle showed that overexpression of
GLUT4 saturates its intracellular compartment resulting in
increased GLUT4 associated with the plasma membrane in the
basal state (44–46), although changes in glucose transport
were modest in some studies. These results, together with our
results with transgenic adipocytes overexpressing GLUT4 in
vivo, indicate that intracellular sequestration of GLUT4 is
saturable. This may involve saturation of multiple steps in
GLUT4 trafficking, including retention of GLUT4 intracellu-
larly as well as recycling of GLUT4 from PM to intracellular
sites. The fact that overexpression of either a GLUT4 (41) or an
IRAP (42) peptide redistributes intracellular GLUT4 to the
plasma membrane suggests both proteins are targeted to a
common intracellular compartment by the same mechanism,
consistent with data in IRAP/ mice (18).
GLUT4 Content Regulates IRAP and VAMP2 Protein Levels
Post-transcriptionally—A second finding of the current study is
that GLUT4 content alters the steady-state levels of other
proteins localizing, at least in part, to the GLUT4 vesicle,
including IRAP and VAMP2. In GLUT4/ adipocytes, IRAP
and VAMP2 levels were decreased (Fig. 2), whereas in GLUT4-
overexpressing adipocytes, levels of these proteins were in-
creased (Fig. 2). These changes were evident in total adipocyte
membranes (Fig. 2) as well as subcellular membrane fractions
(Fig. 3). Changes in IRAP are in agreement with the modest
increase in aminopeptidase activity that we detected previ-
ously in intracellular membranes from GLUT4 vesicles of aP2-
GLUT4-Tg adipocytes (27). In addition, in the current study
the number of IRAP-containing vesicles was increased in
GLUT4-overexpressing adipocytes as detected by immunogold
electron microscopy (Fig. 6B). The reciprocal alterations in
IRAP and VAMP2 protein levels in adipocytes overexpressing
or deficient in GLUT4 suggest that GLUT4 may regulate
steady-state IRAP and VAMP2 protein levels by regulation of
the biogenesis or half-life of the GLUT4-IRAP compartment.
Our data show that in GLUT4 overexpressors, this regulation
is post-transcriptional because steady-state IRAP and VAMP2
mRNA levels do not change with increased GLUT4 content and
may involve changes in mRNA translation rates and/or
changes in protein stability.
Interestingly, decreases of 50–80% in GLUT4 content were
recently reported in muscle, heart, and adipocytes of IRAP/
mice (18). Taken together with our data, these results suggest
that IRAP and GLUT4 can coordinately regulate steady-state
levels of each other and imply that both proteins influence
development of the unique GLUT4/IRAP insulin-responsive
intracellular compartment. As GLUT4 and IRAP are likely
targeted to their shared compartment by a common mechanism
(47), it is not surprising that they may regulate each other.
In contrast to our data, Jiang et al. (48) reported IRAP levels
are decreased 50% in muscle and heart but increased 2-fold in
adipocytes of GLUT4-null mice, and Zhou et al. (49) reported
that denervation down-regulates GLUT4 in muscle, but IRAP
levels remain unchanged. The discrepancy between IRAP lev-
els in adipocytes of GLUT4 null mice and in adipose-specific
GLUT4-deficient mice may relate to decreased fat cell size of
GLUT4 null mice (50). GLUT4-null mice have virtually no
adipose tissue as well as other metabolic abnormalities (50),
which may be complicating factors in interpreting these re-
sults. We did not observe changes in fat cell size in either
aP2-GLUT4/ or aP2-GLUT4-Tg mice (Table I). The discrep-
ancy between IRAP levels in adipocytes of adipose-specific
GLUT4/ mice and denervated muscle may be due to tissue-
specific differences or other changes in gene expression that
would occur with denervation.
Our findings, together with those of others (41, 43–45), fur-
ther support a model in which GLUT4 (and potentially IRAP
FIG. 6. Overexpression of GLUT4
increases the amount of GLUT4 per
vesicle and the number of GLUT4
and IRAP containing vesicles per
cell. Intracellular membrane vesicles
were isolated from control (Con) or adi-
pose-specific GLUT4-overexpressing (TG)
adipocytes, fixed, immunoabsorbed with
antibodies to GLUT4, IRAP, or VAMP2
and gold-labeled secondary antibodies.
Vesicles were visualized by staining with
uranyl acetate and methylcellulose. A,
representative micrographs of vesicles
from control and TG adipocytes stained
for GLUT4 (small gold particle) and
VAMP2 (large gold particle). B, percent-
age of intracellular vesicles containing
GLUT4, IRAP, or VAMP2. C, percentage
of VAMP2 vesicles with GLUT4. D, num-
ber of GLUT4 molecules per vesicle, and
E, GLUT4 vesicle diameter. Results are
means  S.E. for 3–5 separate experi-
ments. Two hundred vesicles were exam-
ined per genotype in each experiment. *,
p  0.05 compared with control.
GLUT4 Amount Affects GLUT4-Vesicle Composition/Localization21604
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(18, 42)) is a determining factor in generating or stabilizing the
unique GLUT4/IRAP intracellular compartment. Neverthe-
less, other studies challenge this model. Antibodies recognizing
GLUT4 perturb in vitro GLUT4 targeting to endosomal vesicles
without interfering with incorporation of IRAP or TfR (51).
Further studies are needed to delineate the precise roles of
GLUT4 and IRAP in generating their common insulin-respon-
sive intracellular compartment and regulating each other’s net
biogenesis.
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